This month we added five new studies to the Best Practice Database, the research repository for Best Practices, LLC. This month's new studies explore three important areas within pharma: Real World Evidence (RWE) Generation, Digital Patient Engagement Programs and Outcomes-Based Contracting. Two of the new studies revolve around RWE in pharma - one examines the current and future utilization of extension studies while the other RWE document looks at the use of intervention studies. Addressing a different topical area are two studies that examine pharma's growing use of digital patient engagement programs. One of the studies presents staffing and spend benchmarks while the other study tackles performance metrics; both look at these issues in global, emerging and developed markets. The last study examines outcomes-based contract initiatives in pharma.
The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.